 Aptorum Group Limited NASDAQ:APM Aptorum Group, a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the closing of a registered direct offering of 1,351,350 Class A ordinary shares at a per share offering price of 7.40. The investors also received accompanying warrants to purchase 1,351,350 of its Class A ordinary shares at an exercise price of 7.40 per share. Participation in the offering includes approximately 6 million from unaffiliated institutional investors and 4 million from Jurchen Investment Corporation, the largest shareholder of Aptorum Group, which is wholly owned by Ian Huen, the Chief Executive Officer and Executive Director of Aptorum Group. 